Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
V. Grinstead, S. Murphy, J. Mukherjee (Warwick, United Kingdom). Compliance with venous thromboembolic (VTE) risk assessment and prophylaxis in medical inpatients at an English DGH. Eur Respir J 2010; 36: Suppl. 54, 3875

Member's Comments

No comment yet.

Related content which might interest you: Venous thromboembolism (VTE) prophylaxis in acute medical admissions to a university hospital Source: Annual Congress 2009 - Pulmonary embolism and cardiovascular diseases Year: 2009 Incidence of venous thromboembolism 8-weeks post discharge in hospitalised medical patients not receiving thrombo-prophylaxis Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease Year: 2008 Primary prophylaxis against venous thromboembolism in medical in-patients: audit of our practice in a large teaching hospital Source: Eur Respir J 2006; 28: Suppl. 50, 45s Year: 2006 Sticker reminders improve VTE prophylaxis appropriatness in hospitalized patients Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease Year: 2010 Hestia criteria can discriminate high- from low-risk patients with pulmonary embolism Source: Eur Respir J 2013; 41: 588-592 Year: 2013 Venous thromboembolism prophylaxis in hospitalised patients with pneumonia: a prospective survey Source: Annual Congress 2009 - Pulmonary embolism and cardiovascular diseases Year: 2009 Are the thromboembolic venous disease prophylaxis guidelines and consensus recommendations being actually followed by physicians at general hospitals? Source: Eur Respir J 2006; 28: Suppl. 50, 47s Year: 2006 Over reliance on D-dimer requests in the diagnosis of venous thromboembolism (VTE) Source: Eur Respir J 2003; 22: Suppl. 45, 220s Year: 2003 Venous thromboembolic (VTE) in patients with ALS: an incidence study Source: Virtual Congress 2021 – Home mechanical ventilation: organisation and outcomes Year: 2021 Improvement of thromboprophylaxis by attaching printed thrombosis risk assessment tool and recommendations to patient‘s hospital charts Source: Annual Congress 2011 - Prediction of pulmonary thromboembolism Year: 2011 The evaluation of medication adherence in patients with pulmonary thromboembolism Source: International Congress 2018 – Acute pulmonary embolism: from diagnosis to treatment Year: 2018 Venous thromboembolism prophylaxis in hospitals in China: a nationwide survey Source: Virtual Congress 2020 – Epidemiology, diagnosis and management of pulmonary embolism Year: 2020 Efficacy and safety of treatment with anticoagulants in patients with unprovoked venous thromboembolism in Korea Source: International Congress 2016 – Acute pulmonary embolism Year: 2016 Fatal recurrent VTE after anticoagulant treatment for unprovoked VTE: a systematic review Source: Eur Respir Rev, 27 (150) 180094; 10.1183/16000617.0094-2018 Year: 2018 Prevalence and incidence of deep venous thrombosis among patients in intensive care unit Source: Eur Respir J 2007; 30: Suppl. 51, 82s Year: 2007 How to prevent VTE in COVID-19 patients?: Chinese & European perspectives Source: ERS webinar 2020: How to prevent VTE in COVID-19 patients?: Chinese & European perspectives Year: 2020 Predicting anticoagulant-related bleeding in patients with venous thromboembolism: a clinically oriented review Source: Eur Respir J 2015; 45: 201-210 Year: 2015 Prevalence and characteristics of venous thromboembolism in severe exacerbation of COPD in a tertiary care hospital in India Source: Virtual Congress 2021 – Pulmonary embolism in non-COVID-19 and COVID-19 patients Year: 2021 COPD and risk of venous thromboembolism and mortality in a general population Source: Eur Respir J 2016; 47: 473-481 Year: 2016 Implementing venous thromboprophylaxis in medical patients: an opt out approach Source: Annual Congress 2009 - Pulmonary embolism Year: 2009